INSMED INC Investing Cash Flow
INSMED INC (INSM) reported Investing Cash Flow of $290.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- INSMED INC net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $24.51M, a 89.24% decline year-over-year.
- INSMED INC net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $265.52M, a 230.20% increase year-over-year.
- INSMED INC net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $389.41M, a 195.55% increase year-over-year.
- INSMED INC net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$762.23M.
- INSMED INC net cash provided by (used in) investing activities for fiscal 2025 was -$64.58M.
- INSMED INC net cash provided by (used in) investing activities for fiscal 2024 was -$583.17M.
- INSMED INC net cash provided by (used in) investing activities for fiscal 2023 was -$223.60M.
- INSMED INC net cash provided by (used in) investing activities for fiscal 2022 was -$34.58M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $290.03M 10-Q · filed 2026-08-06 | $679.44M derived: sum of 3 quarters · filed 2026-08-06 | -$82.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $265.52M 10-Q · filed 2026-05-07 | $654.93M derived: sum of 2 quarters · filed 2026-05-07 | -$107.30M derived: sum of 3 quarters · filed 2026-05-07 | $120.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $389.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$372.82M derived: sum of 2 quarters · filed 2026-02-19 | -$144.99M derived: sum of 3 quarters · filed 2026-08-06 | -$64.58M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$762.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$534.40M derived: sum of 2 quarters · filed 2026-08-06 | -$453.99M 10-Q · filed 2025-10-30 | -$322.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $227.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $308.25M 10-Q · filed 2026-08-06 | $440.00M derived: sum of 3 quarters · filed 2026-08-06 | -$563.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $80.41M 10-Q · filed 2026-05-07 | $212.17M derived: sum of 2 quarters · filed 2026-05-07 | -$791.30M derived: sum of 3 quarters · filed 2026-05-07 | -$798.08M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $131.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$871.71M derived: sum of 2 quarters · filed 2026-02-19 | -$878.50M derived: sum of 3 quarters · filed 2026-02-19 | -$583.17M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.01B derived: sum of 2 quarters · filed 2025-10-30 | -$714.93M 10-Q · filed 2025-10-30 | -$713.13M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $288.54M 10-Q · filed 2025-08-07 | $290.34M derived: sum of 3 quarters · filed 2026-02-19 | $297.49M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $295.32M 10-Q · filed 2025-05-08 | $297.12M derived: sum of 2 quarters · filed 2026-02-19 | $304.27M derived: sum of 3 quarters · filed 2026-02-19 | $30.11M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.95M derived: sum of 2 quarters · filed 2026-02-19 | -$265.21M derived: sum of 3 quarters · filed 2026-02-19 | -$223.60M 10-K · filed 2026-02-19 |
| 2023-09-30 | $7.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$267.01M derived: sum of 2 quarters · filed 2024-10-31 | -$225.41M 10-Q · filed 2024-10-31 | -$205.10M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$274.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$232.55M 10-Q · filed 2024-08-08 | -$212.25M derived: sum of 3 quarters · filed 2025-02-20 | -$162.83M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $41.60M 10-Q · filed 2024-05-09 | $61.91M derived: sum of 2 quarters · filed 2025-02-20 | $111.33M derived: sum of 3 quarters · filed 2025-02-20 | $108.42M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $20.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $69.73M derived: sum of 2 quarters · filed 2025-02-20 | $66.82M derived: sum of 3 quarters · filed 2025-02-20 | -$34.58M 10-K · filed 2025-02-20 |
| 2022-09-30 | $49.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $46.51M derived: sum of 2 quarters · filed 2023-10-26 | -$54.89M 10-Q · filed 2023-10-26 | -$106.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$104.31M 10-Q · filed 2023-08-03 | -$155.53M derived: sum of 3 quarters · filed 2024-02-22 | -$163.93M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$101.41M 10-Q · filed 2023-05-04 | -$152.63M derived: sum of 2 quarters · filed 2024-02-22 | -$161.03M derived: sum of 3 quarters · filed 2024-02-22 | -$164.51M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$51.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$59.62M derived: sum of 2 quarters · filed 2024-02-22 | -$63.10M derived: sum of 3 quarters · filed 2024-02-22 | -$64.28M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$11.89M derived: sum of 2 quarters · filed 2022-10-27 | -$13.07M 10-Q · filed 2022-10-27 | -$14.58M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$4.67M 10-Q · filed 2022-08-04 | -$6.18M derived: sum of 3 quarters · filed 2023-02-23 | -$6.93M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$1.18M 10-Q · filed 2022-05-05 | -$2.70M derived: sum of 2 quarters · filed 2023-02-23 | -$3.44M derived: sum of 3 quarters · filed 2023-02-23 | -$5.32M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$2.26M derived: sum of 2 quarters · filed 2023-02-23 | -$4.14M derived: sum of 3 quarters · filed 2023-02-23 | -$6.82M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$747.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$2.63M derived: sum of 2 quarters · filed 2021-10-28 | -$5.31M 10-Q · filed 2021-10-28 | -$18.34M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.56M 10-Q · filed 2021-08-05 | -$17.60M derived: sum of 3 quarters · filed 2022-02-17 | -$32.19M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | -$2.68M 10-Q · filed 2021-05-06 | -$15.72M derived: sum of 2 quarters · filed 2022-02-17 | -$30.31M derived: sum of 3 quarters · filed 2022-02-17 | -$40.92M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$27.63M derived: sum of 2 quarters · filed 2022-02-17 | -$38.24M derived: sum of 3 quarters · filed 2022-02-17 | -$42.27M 10-K · filed 2022-02-17 |
| 2019-09-30 | -$14.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$25.20M derived: sum of 2 quarters · filed 2020-10-29 | -$29.23M 10-Q · filed 2020-10-29 | -$33.98M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$14.64M 10-Q · filed 2020-08-06 | -$19.39M derived: sum of 3 quarters · filed 2021-02-25 | -$21.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$4.03M 10-Q · filed 2020-04-30 | -$8.78M derived: sum of 2 quarters · filed 2021-02-25 | -$10.63M derived: sum of 3 quarters · filed 2021-02-25 | -$13.48M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$6.60M derived: sum of 2 quarters · filed 2021-02-25 | -$9.45M derived: sum of 3 quarters · filed 2021-02-25 | -$14.81M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$4.70M derived: sum of 2 quarters · filed 2019-10-30 | -$10.06M 10-Q · filed 2019-10-30 | -$11.76M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$8.21M 10-Q · filed 2019-08-01 | -$9.91M derived: sum of 3 quarters · filed 2020-02-25 | -$10.36M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$5.37M 10-Q · filed 2019-05-07 | -$7.07M derived: sum of 2 quarters · filed 2020-02-25 | -$7.51M derived: sum of 3 quarters · filed 2020-02-25 | -$7.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.15M derived: sum of 2 quarters · filed 2020-02-25 | -$2.58M derived: sum of 3 quarters · filed 2020-02-25 | -$3.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$884.00K derived: sum of 2 quarters · filed 2018-10-30 | -$1.30M 10-Q · filed 2018-10-30 | -$2.07M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | -$437.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$854.00K 10-Q · filed 2018-08-02 | -$1.63M derived: sum of 3 quarters · filed 2019-02-22 | -$2.93M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$417.00K 10-Q · filed 2018-05-02 | -$1.19M derived: sum of 2 quarters · filed 2019-02-22 | -$2.49M derived: sum of 3 quarters · filed 2019-02-22 | |
| 2016-12-31 | -$772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$2.07M derived: sum of 2 quarters · filed 2019-02-22 | -$4.20M 10-K · filed 2019-02-22 | |
| 2016-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$3.43M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$2.13M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | -$3.45M 10-K · filed 2018-02-23 | |||
| 2012-12-31 | $44.59M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $44.56M derived: sum of 2 quarters · filed 2013-03-18 | $48.68M derived: sum of 3 quarters · filed 2013-03-18 | $61.52M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $4.09M derived: sum of 2 quarters · filed 2012-11-07 | $16.93M 10-Q · filed 2012-11-07 | $27.41M derived: sum of 4 quarters · filed 2013-03-18 |
| 2012-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $16.96M 10-Q · filed 2012-08-07 | $27.44M derived: sum of 3 quarters · filed 2013-03-18 | $36.08M derived: sum of 4 quarters · filed 2013-03-18 |
| 2012-03-31 | $12.84M 10-Q · filed 2012-05-08 | $23.32M derived: sum of 2 quarters · filed 2013-03-18 | $31.96M derived: sum of 3 quarters · filed 2013-03-18 | $30.71M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-12-31 | $10.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $19.12M derived: sum of 2 quarters · filed 2013-03-18 | $17.87M derived: sum of 3 quarters · filed 2013-03-18 | $34.36M 10-K · filed 2013-03-18 |
| 2011-09-30 | $8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $7.39M derived: sum of 2 quarters · filed 2012-11-07 | $23.88M 10-Q · filed 2012-11-07 | $33.85M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $15.24M 10-Q · filed 2012-08-07 | $25.21M derived: sum of 3 quarters · filed 2013-03-18 | $24.63M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $16.49M 10-Q · filed 2012-05-08 | $26.46M derived: sum of 2 quarters · filed 2013-03-18 | $25.87M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $9.39M derived: sum of 2 quarters · filed 2013-03-18 | $5.96M 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$4.02M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$3.43M 10-Q/A · filed 2011-08-08 | |||
| 2009-12-31 | $18.73M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |